Company
Funding data: Recent Funding. Each amount links to the announcement it came from.
WhiteLab Genomics
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
Rounds
| Date | Stage | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Oct 5, 2026 | Series B+ | $26M | — | AVP, Blast. Club, Debiopharm Innovation Fund, OMNES Capital, YADAY | european-biotechnology.com ↗ |
| Sep 13, 2022 | Series A | undisclosed | — | — | fundraisingfox.com ↗ |
About
- Website
- whitelabgx.com
- X
- @WhitelabG
- Based in
- Paris, France
Founders
- David Del BourgoCEO co-founder
- Cedric OdjeFounder
- Julien CottineauFounder
- Lucia CinqueCo-Founder & Chief of Staff
Investors
AVP · Blast. Club · Debiopharm Group · Debiopharm Innovation Fund · OMNES Capital · Y Combinator · YADAY